株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の幹細胞市場

The Global Market for Stem Cells

発行 BCC Research 商品コード 63236
出版日 ページ情報 英文 162 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.09円で換算しております。
Back to Top
世界の幹細胞市場 The Global Market for Stem Cells
出版日: 2018年03月22日 ページ情報: 英文 162 Pages
担当者のコメント
治療法概要から特許、市場状況、参入企業等を包括的に纏めています。
概要

世界の幹細胞市場は、2017年の74億米ドルから、2022年までに148億米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、14.7%の成長が予測されています。

当レポートでは、世界の幹細胞市場について調査分析し、市場概要、市場動向と予測、成長可能性と将来の応用、主要促進要因、地域別の市場動向、産業動向、主要ベンダーのプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 幹細胞市場の概要

  • 細胞
  • 幹細胞

第4章 幹細胞研究

  • 歴史
  • ES (胚性幹) 細胞
  • 成体幹細胞
  • 臍帯血幹細胞
  • iPS (人工多能性幹) 細胞
  • 細胞ベースの治療
  • 治療用幹細胞バンク
  • 幹細胞ベースの生物医学研究
  • 幹細胞研究センター
  • 幹細胞研究の規制
  • 幹細胞研究・産生の実用性
  • 幹細胞バンク

第5章 幹細胞の応用

  • 再生医療
  • 現在の幹細胞治療応用
    • 筋萎縮性側索硬化症 (ALS)
    • パーキンソン病
    • 脊髄損傷 (SCI)
    • アルツハイマー病
    • 心臓病
    • 末梢動脈疾患
    • 1型糖尿病
    • 整形外科修復
    • 肝不全
    • 移植片対宿主病 (GVHD)
    • 肺疾患

第6章 幹細胞の特許

  • 特許の一般的背景
    • 幹細胞の特許
  • 政策:国別
    • 米国
    • カナダ
    • EPC
    • 英国
    • ドイツ
    • 日本
    • 中国
    • iPS細胞

第7章 幹細胞市場

  • 幹細胞市場
    • 市場促進要因
  • 市場の機会:薬効分類別
    • 心血管疾患
    • 心筋梗塞
    • 中枢神経系疾患
    • 脊髄損傷
    • 神経変性疾患
    • 糖尿病
    • 骨格系
  • 世界市場の推計と予測
  • 地域/国別の市場分析
    • 南北アメリカ
    • 欧州
    • アジア太平洋地域
    • その他

第8章 企業プロファイル

付録

BCC Researchについて

目次
Product Code: BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Report Includes

  • 42 data tables and 18 additional tables
  • An overview of the global market for stem cells
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including Cellular Dynamics International, Inc., Celyad, Cytori Therapeutics, Inc., Epistem Ltd. and Gamida-Cell Ltd.

Report Scope

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Analyst Credentials

Paul Evers has been involved in pharmaceutical and medical market analysis for 20 years. He has authored previous BCC Research reports on the stem cell marketplace, the major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Scope of Report
  • Market Analyses and Forecasts
  • Methodology
  • Intended Audience
  • Information Sources
  • Analyst's Credentials
  • Related BCC Research Reports.

Chapter 2: Summary and Highlights

  • Definitions
  • Applications
  • Research and Commercialization
  • Funding
  • Market

Chapter 3: Overview

  • Cells
  • Stem Cells
    • Induced Pluripotent Stem Cells

Chapter 4: Stem Cell Research

  • History
  • Embryonic Stem Cells
    • Growth and Identification of Embryonic Stem Cells
    • Stimulating Embryonic Stem Cells to Differentiate
  • Adult Stem Cells
    • Mesechymal Stem Cells
    • Hematopoietic Stem Cells
    • Neural Stem Cell
    • Endothelial Progenitor Cell.
    • Epithelial Stem Cell
    • Very Small Embryonic-Like Cell
  • Cord Blood Stem Cells
  • Induced Pluripotent Stem Cells
    • Nuclear Reprogramming
  • Cell-Based Therapeutics
    • Embryonic-Derived Stem Cells
    • Adult and Progenitor-Derived Stem Cells
    • Engineered Stem Cells for Transplantation
  • Therapeutic Stem Cell Banking
  • Stem-Cell-Based Biomedical Research
  • Stem Cell Research Centers
  • Regulation of Stem Cell Research
    • National Regulatory Measures
  • Practicalities of Stem Cell Research and Production
    • Stem Cell Production
    • Stem Cell Acquisition
    • Stem Cell Production Economics
    • Customized Therapy
    • Banks
    • Novel Stem Cell Production Developments
    • Isolation and Engineering
    • Adult Stem Cells
    • Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Bioprinting
  • Stem Cell Banking

Chapter 5: Stem Cell Applications

  • Regenerative Medicine
  • Current Stem Cell Therapy Applications
    • Cancer
    • Amyotrophic Lateral Sclerosis
    • Parkinson's Disease
    • Spinal Cord Injury
    • Alzheimer's Disease
    • Heart Disease
    • Peripheral Arterial Disease
    • Type 1 Diabetes
    • Orthopedic Repair
    • Liver Failure
    • Graft-Versus-Host Disease
    • Lung Disease

Chapter 6: Stem Cell Patents

  • General Background on Patents
    • Stem Cell Patents
  • Policies by Country
    • U.S.
    • Canada
    • EPC
    • U.K.
    • Germany
    • Japan
    • China
    • Induced Pluripotent Stem Cells
  • Recent Patent Activity

Chapter 7: Stem Cell Markets

  • Markets for Stem Cells
    • Market Drivers
  • Market Opportunities by Therapeutic Class
    • Cancer
    • Cardiovascular Disease
    • Myocardial Infarction
    • Central Nervous System Disease
    • Spinal Cord Injury
    • Neurodegenerative Diseases.
    • Diabetes Mellitus
    • Skeletal System
  • Global Market Estimates and Forecasts
  • Regional and National Market Analysis
    • Americas
    • U.S.
    • Canada
    • Brazil
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • U.K.
  • Asia-Pacific
    • Market Opportunities by Disease Category
    • Japan
    • China
    • India
    • Rest of World

Chapter 8: Company Profiles

Appendix 1: Glossary

Appendix 2: Significant Stem Cell Research Patents

About BCC Research

  • About BCC Research.
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table Global Stem Cell Market, by Region, Through 2022 ($ Millions)
  • Table 1 Bioprinting Emerging Platforms
  • Table 2 Countries Engaged in the ISCBI Program, 2017
  • Table 3 Yamanaka's Induced Pluripotent Stem-Related Patents, 2011
  • Table 4 Stem Cell Patents, by Type, 2011
  • Table 5 Global Healthcare Systems, 2017
  • Table 6 Companies Developing Stem Cell Therapies for Cardiovascular Diseases, 2017
  • Table 7 U.S. Statistics for Spinal Cord Injury, 2017
  • Table 8 Global Neurodegenerative Diseases, 2015
  • Table 9 U.S. Statistics for Diabetes, 2015
  • Table 10 Global Market for Diabetes Mellitus, Treatments and Devices, Through 2022 ($ Billions)
  • Table 11 Global Stem Cell Market, by Region, Through 2022 ($ Millions)
  • Table 12 Stem Cell Market, by Country, Through 2022 ($ Millions)
  • Table 13 Potential U.S. Patient Populations for Cell-Based Therapies, 2016
  • Table 14 U.S. Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 15 U.S. Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 16 U.S. Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 17 Canadian Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 18 Canadian Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 19 Canadian Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 20 Brazilian Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 21 Brazilian Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 22 Brazilian Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 23 Mexican Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 24 Mexican Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 25 European Stem Cell Market, by Country, Through 2022 ($ Millions)
  • Table 26 European Statistics for Cardiovascular Disease, 2017
  • Table 27 European Rate of Death from Heart Disease, by Country, 2016 (Deaths per 100,000 Cases)
  • Table 28 European Statistics for Central Nervous System Disorders and Injuries, 2016
  • Table 29 European Statistics for Spinal Cord Injury and Parkinson's Disease, by Country, 2016
  • Table 30 European Prevalence of Diabetic Patients, by Country, 2017 (No. of Patients)
  • Table 31 French Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 32 French Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 33 French Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 34 German Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 35 German Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 36 German Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 37 Italian Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 38 Italian Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 39 Italian Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 40 Spanish Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 41 Spanish Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 42 Spanish Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 43 U.K. Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 44 U.K. Stem Cell Research and Services Market, Through 2022 ($Millions)
  • Table 45 U.K. Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 46 China and India Statistics for Cardiovascular Disease, 2016
  • Table 47 Asia-Pacific Stem Cell Policies, 2017
  • Table 48 Asia-Pacific Stem Cell Market, by Country, Through 2022 ($ Millions)
  • Table 49 Japanese Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 50 Japanese Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 51 Japanese Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 52 Chinese Stem Cell Therapy Market, Through 2022 ($ Millions).
  • Table 53 Chinese Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 54 Chinese Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 55 Potential Candidates for Stem Cell Therapy in India, 2016
  • Table 56 Indian Stem Cell Therapy Market, Through 2022 ($ Millions)
  • Table 57 Indian Stem Cell Research and Services Market, Through 2022 ($ Millions)
  • Table 58 Indian Stem Cell Cord Blood Services Market, Through 2022 ($ Millions)
  • Table 59 Stem Cell Market in the Rest of the World, Through 2022 ($ Millions)

List of Figures

  • Summary Figure Global Stem Cell Market, by Region, 2015-2022 ($ Millions)
  • Figure 1 Early Development of Embryo
Back to Top